GENE ONLINE|News &
Opinion
Blog

Clinical Trial
Trials & Approvals Cancer ImmunotherapyRoche
Cancer Immunotherapy Phase III Trial Yields Positive Results
2022-08-02
Trials & Approvals Clinical TrialCancer
Bristol Myers Squibb Provides an Update on Kidney Cancer Treatment
2022-08-01
R&D Cardiovascular Disease
Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals
2022-07-28
Trials & Approvals Gene Editing
FDA Lifts Hold on LogicBio’s Gene Editing Program
2022-05-10
R&D Breast Cancer
REVEAL GENOMICS and Dana-Farber Cancer Institute Team Up to Research Breast Cancer
2022-04-29
Go Prime CRISPR
These Two Companies are Helping Push Denmark to the Forefront of Biotech
2022-04-21
Regulatory Alzheimer's Drug
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC
2022-03-30
COVID-19 COVID-19 Treatment
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
Feature FDA
FDA Announces Draft Guidances on Genome Editing and CAR T Cell Therapy
2022-03-25
Technology AI
No Real-Life Placebo Required – Deriving Virtual Control Group Data by Machine Learning
2022-03-16
Manufacturing Supply Chain
How Did the Russian Invasion of Ukraine Affect Global Biopharma?
2022-03-16
Trials & Approvals Myasthenia Gravis
argenx’s Novel Treatment for Myasthenia Gravis gets FDA Nod
2021-12-21
Special China
How is China Driving Global Progress in Innovation and Access? – A Discussion with BeiGene CEO John Oyler
2021-11-16
Asia-Pacific Decentralized Trial
Are Decentralized Clinical Trials Taking Root in Japan?
2021-10-29
1 2 3 4 … 14
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top